The biopharma specialist has made a flurry of major new purchases in recent weeks.
The Latest
Ultimately, many allocators want to actively manage their PE portfolios, and are exploring everything from automatic secondary sales to third-party leverage, says TRS’s Scott Ramsower.
Cynthia Steer, an advisor to Institutional Investor, considers the losses to the industry of long tenured execs and the potential gains from the next generation.
More Articles
Sponsored
Sponsored